Both the protein used and the conjugation method are factors which may
be relevant for targeting infection with In-111-labelled proteins. In
this study, human immunoglobulin G (IgG), conjugated to either DTPA o
r LiLo, and LiLo conjugated human immunoglobulin M (IgM) were evaluate
d. In rats with Staphylococcus aureus calf muscle infection, biodistri
bution was determined 6, 24 and 48 h after the injection of In-111-DTP
A-IgG, In-111-LiLo-IgG or In-111-LiLo-IgM. Absolute abscess uptake of
In-111-LiLo-IgG was significantly higher than that of In-111-DTPA-IgG
(P < 0.05). Since blood clearance of In-111-LiLo-IgG was initially sig
nificantly slower(P < 0.01), the higher abscess uptake did not result
in higher abscess-to-background ratios. In-111-LiLo-IgG accumulated to
a greater extent in the Liver (P < 0.001). In-111-DTPA-IgG showed hig
her uptake in the kidneys and bone marrow (P < 0.001 and P < 0.01, res
pectively). Although decreasing over time, In-111-LiLo-IgM showed reas
onable abscess uptake and rapid blood clearance, resulting in higher a
bscess-to-background ratios compared with In-111-LiLo-IgG (P < 0.01).
However, liver and spleen uptake were three- to four-fold higher than
that of In-111-LiLo-IgG (P < 0.001). Compared with DTPA-conjugation, c
helation with LiLo has a minor influence on abscess targeting of In-11
1-labelled IgG. However, differences in blood clearance and organ upta
ke do occur. In-111-LiLo-IgM shows high relative accumulation in absce
sses as well as high Liver and spleen uptake. In-111-LiLo-IgM appears
promising for imaging infection outside the hunk region.